Category Archives: Healthcare

Analysts Are Bullish on These Healthcare Stocks: ABT, SHPG

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Abbott Labs (NYSE: ABT) and Shire (NASDAQ: SHPG) with bullish sentiments. Abbott Labs (NYSE: ABT) Cowen & Co. analyst Josh Jennings reiterated

Medtronic Receives a Buy from RBC Capital

In a report released yesterday, Glenn Novarro from RBC Capital reiterated a Buy rating on Medtronic (NYSE: MDT), with a price target of $90. The company’s shares closed yesterday at $79.70. According to TipRanks.com, Novarro is a 5-star analyst with

RBC Capital Sticks to Its Hold Rating for Hologic

RBC Capital analyst Glenn Novarro reiterated a Hold rating on Hologic (NASDAQ: HOLX) yesterday and set a price target of $42. The company’s shares closed yesterday at $37.57. According to TipRanks.com, Novarro is a 5-star analyst with an average return

RBC Capital Keeps a Buy Rating on K2M Group Holdings

RBC Capital analyst Glenn Novarro reiterated a Buy rating on K2M Group Holdings (NASDAQ: KTWO) yesterday and set a price target of $26. The company’s shares closed yesterday at $20.85. According to TipRanks.com, Novarro is a 5-star analyst with an

Analysts Offer Insights on Healthcare Companies: Akari Therapeutics (NASDAQ: AKTX) and Impax Laboratories (NASDAQ: IPXL)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Akari Therapeutics (NASDAQ: AKTX) and Impax Laboratories (NASDAQ: IPXL). Akari Therapeutics (NASDAQ: AKTX) In a report released yesterday, Arlinda Lee from Canaccord Genuity reiterated a

Five Prime Therapeutics Gets a Hold Rating from BMO Capital

BMO Capital analyst Ian Somaiya reiterated a Hold rating on Five Prime Therapeutics (NASDAQ: FPRX) on September 20 and set a price target of $39. The company’s shares opened today at $35.11. According to TipRanks.com, Somaiya is a 5-star analyst